Cancer BiologyCancer Gene TherapyPeer-reviewed
Identification of ribosomal protein eL21 as a novel externalized protein and a potential target in triple negative breast cancer
Lucie Arnould, Nina Radosevic‐Robin, Laura Duranton…·Frédéric Catez
This study identifies eL21 as an externalized ribosomal protein in triple negative breast cancer cells and shows anti-eL21 antibodies induce anti-proliferative effects.
DOI 10.1038/s41417-026-01026-7